ID   MAP7_HUMAN              Reviewed;         749 AA.
AC   Q14244; B7Z290; B7Z400; B7Z5S7; B7Z9U7; C9JPS0; E9PCP3; F5H1E2; Q7Z6S0;
AC   Q8TAU5; Q9NY82; Q9NY83;
DT   31-OCT-2006, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1996, sequence version 1.
DT   18-JUN-2025, entry version 189.
DE   RecName: Full=Ensconsin;
DE   AltName: Full=Epithelial microtubule-associated protein of 115 kDa;
DE            Short=E-MAP-115;
DE   AltName: Full=Microtubule-associated protein 7;
DE            Short=MAP-7;
GN   Name=MAP7;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), FUNCTION, TISSUE SPECIFICITY, AND
RP   SUBCELLULAR LOCATION.
RX   PubMed=8408219; DOI=10.1083/jcb.123.2.357;
RA   Masson D., Kreis T.E.;
RT   "Identification and molecular characterization of E-MAP-115, a novel
RT   microtubule-associated protein predominantly expressed in epithelial
RT   cells.";
RL   J. Cell Biol. 123:357-371(1993).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 2 AND 3).
RA   Fabre-Jonca N., Masson D.;
RT   "Novel features of E-MAP-115 revealed by the characterization of its
RT   variants E-MAP-115/105 and E-MAP-115/95.";
RL   Submitted (MAY-1999) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 4; 5; 6 AND 7), AND
RP   VARIANT TRP-558.
RC   TISSUE=Amygdala, Hippocampus, and Thalamus;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=14574404; DOI=10.1038/nature02055;
RA   Mungall A.J., Palmer S.A., Sims S.K., Edwards C.A., Ashurst J.L.,
RA   Wilming L., Jones M.C., Horton R., Hunt S.E., Scott C.E., Gilbert J.G.R.,
RA   Clamp M.E., Bethel G., Milne S., Ainscough R., Almeida J.P., Ambrose K.D.,
RA   Andrews T.D., Ashwell R.I.S., Babbage A.K., Bagguley C.L., Bailey J.,
RA   Banerjee R., Barker D.J., Barlow K.F., Bates K., Beare D.M., Beasley H.,
RA   Beasley O., Bird C.P., Blakey S.E., Bray-Allen S., Brook J., Brown A.J.,
RA   Brown J.Y., Burford D.C., Burrill W., Burton J., Carder C., Carter N.P.,
RA   Chapman J.C., Clark S.Y., Clark G., Clee C.M., Clegg S., Cobley V.,
RA   Collier R.E., Collins J.E., Colman L.K., Corby N.R., Coville G.J.,
RA   Culley K.M., Dhami P., Davies J., Dunn M., Earthrowl M.E., Ellington A.E.,
RA   Evans K.A., Faulkner L., Francis M.D., Frankish A., Frankland J.,
RA   French L., Garner P., Garnett J., Ghori M.J., Gilby L.M., Gillson C.J.,
RA   Glithero R.J., Grafham D.V., Grant M., Gribble S., Griffiths C.,
RA   Griffiths M.N.D., Hall R., Halls K.S., Hammond S., Harley J.L., Hart E.A.,
RA   Heath P.D., Heathcott R., Holmes S.J., Howden P.J., Howe K.L., Howell G.R.,
RA   Huckle E., Humphray S.J., Humphries M.D., Hunt A.R., Johnson C.M.,
RA   Joy A.A., Kay M., Keenan S.J., Kimberley A.M., King A., Laird G.K.,
RA   Langford C., Lawlor S., Leongamornlert D.A., Leversha M., Lloyd C.R.,
RA   Lloyd D.M., Loveland J.E., Lovell J., Martin S., Mashreghi-Mohammadi M.,
RA   Maslen G.L., Matthews L., McCann O.T., McLaren S.J., McLay K., McMurray A.,
RA   Moore M.J.F., Mullikin J.C., Niblett D., Nickerson T., Novik K.L.,
RA   Oliver K., Overton-Larty E.K., Parker A., Patel R., Pearce A.V., Peck A.I.,
RA   Phillimore B.J.C.T., Phillips S., Plumb R.W., Porter K.M., Ramsey Y.,
RA   Ranby S.A., Rice C.M., Ross M.T., Searle S.M., Sehra H.K., Sheridan E.,
RA   Skuce C.D., Smith S., Smith M., Spraggon L., Squares S.L., Steward C.A.,
RA   Sycamore N., Tamlyn-Hall G., Tester J., Theaker A.J., Thomas D.W.,
RA   Thorpe A., Tracey A., Tromans A., Tubby B., Wall M., Wallis J.M.,
RA   West A.P., White S.S., Whitehead S.L., Whittaker H., Wild A., Willey D.J.,
RA   Wilmer T.E., Wood J.M., Wray P.W., Wyatt J.C., Young L., Younger R.M.,
RA   Bentley D.R., Coulson A., Durbin R.M., Hubbard T., Sulston J.E., Dunham I.,
RA   Rogers J., Beck S.;
RT   "The DNA sequence and analysis of human chromosome 6.";
RL   Nature 425:805-811(2003).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), AND VARIANT TRP-558.
RC   TISSUE=Pancreas;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   PHOSPHORYLATION.
RX   PubMed=7490279; DOI=10.1083/jcb.131.4.1015;
RA   Masson D., Kreis T.E.;
RT   "Binding of E-MAP-115 to microtubules is regulated by cell cycle-dependent
RT   phosphorylation.";
RL   J. Cell Biol. 131:1015-1024(1995).
RN   [7]
RP   FUNCTION, SUBCELLULAR LOCATION, AND TISSUE SPECIFICITY.
RX   PubMed=9989799; DOI=10.1046/j.1523-1747.1999.00500.x;
RA   Fabre-Jonca N., Viard I., French L.E., Masson D.;
RT   "Upregulation and redistribution of E-MAP-115 (epithelial microtubule-
RT   associated protein of 115 kDa) in terminally differentiating keratinocytes
RT   is coincident with the formation of intercellular contacts.";
RL   J. Invest. Dermatol. 112:216-225(1999).
RN   [8]
RP   FUNCTION.
RX   PubMed=11719555; DOI=10.1242/jcs.114.21.3885;
RA   Bulinski J.C., Odde D.J., Howell B.J., Salmon T.D., Waterman-Storer C.M.;
RT   "Rapid dynamics of the microtubule binding of ensconsin in vivo.";
RL   J. Cell Sci. 114:3885-3897(2001).
RN   [9]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-209; SER-219; SER-254 AND
RP   THR-277, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=16964243; DOI=10.1038/nbt1240;
RA   Beausoleil S.A., Villen J., Gerber S.A., Rush J., Gygi S.P.;
RT   "A probability-based approach for high-throughput protein phosphorylation
RT   analysis and site localization.";
RL   Nat. Biotechnol. 24:1285-1292(2006).
RN   [10]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-219, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17924679; DOI=10.1021/pr070152u;
RA   Yu L.R., Zhu Z., Chan K.C., Issaq H.J., Dimitrov D.S., Veenstra T.D.;
RT   "Improved titanium dioxide enrichment of phosphopeptides from HeLa cells
RT   and high confident phosphopeptide identification by cross-validation of
RT   MS/MS and MS/MS/MS spectra.";
RL   J. Proteome Res. 6:4150-4162(2007).
RN   [11]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-209 AND SER-219, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18220336; DOI=10.1021/pr0705441;
RA   Cantin G.T., Yi W., Lu B., Park S.K., Xu T., Lee J.-D., Yates J.R. III;
RT   "Combining protein-based IMAC, peptide-based IMAC, and MudPIT for efficient
RT   phosphoproteomic analysis.";
RL   J. Proteome Res. 7:1346-1351(2008).
RN   [12]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-209, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;
RA   Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,
RA   Greff Z., Keri G., Stemmann O., Mann M.;
RT   "Kinase-selective enrichment enables quantitative phosphoproteomics of the
RT   kinome across the cell cycle.";
RL   Mol. Cell 31:438-448(2008).
RN   [13]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-209; SER-219; THR-231;
RP   SER-254 AND THR-277, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [14]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS SPECTROMETRY
RP   [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J., Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in a
RT   refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [15]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-209; SER-219; THR-277 AND
RP   THR-673, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full phosphorylation
RT   site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [16]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [17]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-183, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J., Johansen P.T.,
RA   Kratchmarova I., Kassem M., Mann M., Olsen J.V., Blagoev B.;
RT   "System-wide temporal characterization of the proteome and phosphoproteome
RT   of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [18]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-161; SER-165; SER-183;
RP   SER-200; SER-202; SER-209; SER-219; THR-231; THR-277; SER-282; SER-335 AND
RP   SER-365, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [19]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-235 AND SER-365, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [20]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-406, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25218447; DOI=10.1038/nsmb.2890;
RA   Hendriks I.A., D'Souza R.C., Yang B., Verlaan-de Vries M., Mann M.,
RA   Vertegaal A.C.;
RT   "Uncovering global SUMOylation signaling networks in a site-specific
RT   manner.";
RL   Nat. Struct. Mol. Biol. 21:927-936(2014).
RN   [21]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-406, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25114211; DOI=10.1073/pnas.1413825111;
RA   Impens F., Radoshevich L., Cossart P., Ribet D.;
RT   "Mapping of SUMO sites and analysis of SUMOylation changes induced by
RT   external stimuli.";
RL   Proc. Natl. Acad. Sci. U.S.A. 111:12432-12437(2014).
RN   [22]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-406, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25772364; DOI=10.1016/j.celrep.2015.02.033;
RA   Hendriks I.A., Treffers L.W., Verlaan-de Vries M., Olsen J.V.,
RA   Vertegaal A.C.;
RT   "SUMO-2 orchestrates chromatin modifiers in response to DNA damage.";
RL   Cell Rep. 10:1778-1791(2015).
RN   [23]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-273; LYS-295; LYS-373; LYS-377
RP   AND LYS-406, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RX   PubMed=28112733; DOI=10.1038/nsmb.3366;
RA   Hendriks I.A., Lyon D., Young C., Jensen L.J., Vertegaal A.C.,
RA   Nielsen M.L.;
RT   "Site-specific mapping of the human SUMO proteome reveals co-modification
RT   with phosphorylation.";
RL   Nat. Struct. Mol. Biol. 24:325-336(2017).
CC   -!- FUNCTION: Microtubule-stabilizing protein that may play an important
CC       role during reorganization of microtubules during polarization and
CC       differentiation of epithelial cells. Associates with microtubules in a
CC       dynamic manner. May play a role in the formation of intercellular
CC       contacts. Colocalization with TRPV4 results in the redistribution of
CC       TRPV4 toward the membrane and may link cytoskeletal microfilaments.
CC       {ECO:0000269|PubMed:11719555, ECO:0000269|PubMed:8408219,
CC       ECO:0000269|PubMed:9989799}.
CC   -!- SUBUNIT: Interacts with TRPV4. {ECO:0000250}.
CC   -!- INTERACTION:
CC       Q14244; Q6NSX1: CCDC70; NbExp=3; IntAct=EBI-2211064, EBI-6873045;
CC       Q14244; Q8N3C7: CLIP4; NbExp=3; IntAct=EBI-2211064, EBI-5655540;
CC       Q14244; Q8NC26: ZNF114; NbExp=3; IntAct=EBI-2211064, EBI-10265237;
CC       Q14244; A0A0H3JP21: espL2; Xeno; NbExp=4; IntAct=EBI-2211064, EBI-13951059;
CC       Q14244; Q8XBX8: nleB1; Xeno; NbExp=4; IntAct=EBI-2211064, EBI-10039153;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm, perinuclear region. Basolateral cell
CC       membrane. Cytoplasm, cytoskeleton. Note=Colocalized on microtubules. An
CC       intracellular redistribution is triggered during induction of
CC       keratinocyte terminal differentiation from microtubules with a
CC       perinuclear localization to cortical microtubules organized in spike-
CC       like bundles facing intercellular contacts.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=7;
CC       Name=1;
CC         IsoId=Q14244-1; Sequence=Displayed;
CC       Name=2; Synonyms=E-MAP-115-105;
CC         IsoId=Q14244-2; Sequence=VSP_021317;
CC       Name=3; Synonyms=E-MAP-115-95;
CC         IsoId=Q14244-3; Sequence=VSP_021316;
CC       Name=4;
CC         IsoId=Q14244-4; Sequence=VSP_043336, VSP_021317;
CC       Name=5;
CC         IsoId=Q14244-5; Sequence=VSP_043335;
CC       Name=6;
CC         IsoId=Q14244-6; Sequence=VSP_046758;
CC       Name=7;
CC         IsoId=Q14244-7; Sequence=VSP_043336;
CC   -!- TISSUE SPECIFICITY: Expressed in the skin and cells of epithelial
CC       origin. Predominantly expressed in the suprabasal layers of the normal
CC       epidermis and relatively abundant in squamous cell carcinomas but
CC       barely detectable in basal cell carcinomas.
CC       {ECO:0000269|PubMed:8408219, ECO:0000269|PubMed:9989799}.
CC   -!- INDUCTION: Up-regulated upon terminal differentiation of primary
CC       keratinocytes.
CC   -!- PTM: The association with microtubules is regulated by phosphorylation
CC       during the cell cycle. During interphase only phosphorylated on serine.
CC       Phosphorylated on threonine in mitosis. {ECO:0000269|PubMed:7490279}.
CC   -!- SIMILARITY: Belongs to the MAP7 family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; X73882; CAA52086.1; -; mRNA.
DR   EMBL; AJ242501; CAB88030.1; -; mRNA.
DR   EMBL; AJ242502; CAB88031.1; -; mRNA.
DR   EMBL; AK294461; BAH11776.1; -; mRNA.
DR   EMBL; AK296556; BAH12386.1; -; mRNA.
DR   EMBL; AK299355; BAH13013.1; -; mRNA.
DR   EMBL; AK316062; BAH14433.1; -; mRNA.
DR   EMBL; AL024508; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL023284; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL133511; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC025777; AAH25777.1; -; mRNA.
DR   CCDS; CCDS5178.1; -. [Q14244-1]
DR   CCDS; CCDS56452.1; -. [Q14244-5]
DR   CCDS; CCDS56453.1; -. [Q14244-6]
DR   CCDS; CCDS56454.1; -. [Q14244-4]
DR   CCDS; CCDS56455.1; -. [Q14244-7]
DR   CCDS; CCDS75528.1; -. [Q14244-3]
DR   CCDS; CCDS75529.1; -. [Q14244-2]
DR   PIR; I37356; I37356.
DR   RefSeq; NP_001185537.1; NM_001198608.3. [Q14244-7]
DR   RefSeq; NP_001185538.1; NM_001198609.1.
DR   RefSeq; NP_001185540.1; NM_001198611.3. [Q14244-4]
DR   RefSeq; NP_001185543.1; NM_001198614.2. [Q14244-7]
DR   RefSeq; NP_001185544.1; NM_001198615.3. [Q14244-6]
DR   RefSeq; NP_001185545.1; NM_001198616.3. [Q14244-2]
DR   RefSeq; NP_001185546.1; NM_001198617.3. [Q14244-3]
DR   RefSeq; NP_001185547.1; NM_001198618.2. [Q14244-5]
DR   RefSeq; NP_001185548.1; NM_001198619.2. [Q14244-5]
DR   RefSeq; NP_001375261.1; NM_001388332.1. [Q14244-7]
DR   RefSeq; NP_001375262.1; NM_001388333.1. [Q14244-7]
DR   RefSeq; NP_001375269.1; NM_001388340.1. [Q14244-4]
DR   RefSeq; NP_001375270.1; NM_001388341.1. [Q14244-4]
DR   RefSeq; NP_001375277.1; NM_001388348.1. [Q14244-5]
DR   RefSeq; NP_001375278.1; NM_001388349.1. [Q14244-5]
DR   RefSeq; NP_003971.1; NM_003980.6. [Q14244-1]
DR   RefSeq; XP_006715663.1; XM_006715600.2.
DR   RefSeq; XP_016866960.1; XM_017011471.1.
DR   PDB; 7SGS; EM; 3.30 A; A=1-749.
DR   PDBsum; 7SGS; -.
DR   AlphaFoldDB; Q14244; -.
DR   EMDB; EMD-19043; -.
DR   EMDB; EMD-19044; -.
DR   EMDB; EMD-25120; -.
DR   SMR; Q14244; -.
DR   BioGRID; 114515; 280.
DR   FunCoup; Q14244; 1058.
DR   IntAct; Q14244; 184.
DR   MINT; Q14244; -.
DR   STRING; 9606.ENSP00000482335; -.
DR   GlyGen; Q14244; 3 sites, 1 N-linked glycan (1 site), 1 O-linked glycan (1 site).
DR   iPTMnet; Q14244; -.
DR   PhosphoSitePlus; Q14244; -.
DR   BioMuta; MAP7; -.
DR   DMDM; 74739817; -.
DR   jPOST; Q14244; -.
DR   MassIVE; Q14244; -.
DR   PaxDb; 9606-ENSP00000482335; -.
DR   PeptideAtlas; Q14244; -.
DR   ProteomicsDB; 19484; -.
DR   ProteomicsDB; 25627; -.
DR   ProteomicsDB; 59940; -. [Q14244-1]
DR   ProteomicsDB; 59941; -. [Q14244-2]
DR   ProteomicsDB; 59942; -. [Q14244-3]
DR   ProteomicsDB; 59943; -. [Q14244-4]
DR   ProteomicsDB; 59944; -. [Q14244-5]
DR   Pumba; Q14244; -.
DR   Antibodypedia; 33011; 153 antibodies from 24 providers.
DR   DNASU; 9053; -.
DR   Ensembl; ENST00000354570.8; ENSP00000346581.2; ENSG00000135525.19. [Q14244-1]
DR   Ensembl; ENST00000432797.6; ENSP00000414879.2; ENSG00000135525.19. [Q14244-5]
DR   Ensembl; ENST00000438100.6; ENSP00000400790.2; ENSG00000135525.19. [Q14244-4]
DR   Ensembl; ENST00000454590.5; ENSP00000414712.1; ENSG00000135525.19. [Q14244-7]
DR   Ensembl; ENST00000544465.5; ENSP00000445737.1; ENSG00000135525.19. [Q14244-6]
DR   Ensembl; ENST00000611373.1; ENSP00000482998.1; ENSG00000135525.19. [Q14244-5]
DR   Ensembl; ENST00000616617.4; ENSP00000483511.1; ENSG00000135525.19. [Q14244-3]
DR   Ensembl; ENST00000618822.4; ENSP00000482356.1; ENSG00000135525.19. [Q14244-2]
DR   GeneID; 9053; -.
DR   KEGG; hsa:9053; -.
DR   MANE-Select; ENST00000354570.8; ENSP00000346581.2; NM_003980.6; NP_003971.1.
DR   UCSC; uc003qgz.4; human. [Q14244-1]
DR   AGR; HGNC:6869; -.
DR   CTD; 9053; -.
DR   DisGeNET; 9053; -.
DR   GeneCards; MAP7; -.
DR   HGNC; HGNC:6869; MAP7.
DR   HPA; ENSG00000135525; Tissue enhanced (brain).
DR   MalaCards; MAP7; -.
DR   MIM; 604108; gene.
DR   OpenTargets; ENSG00000135525; -.
DR   VEuPathDB; HostDB:ENSG00000135525; -.
DR   eggNOG; ENOG502QTDQ; Eukaryota.
DR   GeneTree; ENSGT00950000182941; -.
DR   HOGENOM; CLU_017315_2_1_1; -.
DR   InParanoid; Q14244; -.
DR   OrthoDB; 8948920at2759; -.
DR   PAN-GO; Q14244; 2 GO annotations based on evolutionary models.
DR   PhylomeDB; Q14244; -.
DR   PathwayCommons; Q14244; -.
DR   SignaLink; Q14244; -.
DR   BioGRID-ORCS; 9053; 14 hits in 1155 CRISPR screens.
DR   ChiTaRS; MAP7; human.
DR   GeneWiki; MAP7; -.
DR   GenomeRNAi; 9053; -.
DR   Pharos; Q14244; Tbio.
DR   PRO; PR:Q14244; -.
DR   Proteomes; UP000005640; Chromosome 6.
DR   RNAct; Q14244; protein.
DR   Bgee; ENSG00000135525; Expressed in endothelial cell and 188 other cell types or tissues.
DR   ExpressionAtlas; Q14244; baseline and differential.
DR   GO; GO:0030424; C:axon; ISS:ARUK-UCL.
DR   GO; GO:0016323; C:basolateral plasma membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0005874; C:microtubule; IEA:UniProtKB-KW.
DR   GO; GO:0005875; C:microtubule associated complex; TAS:ProtInc.
DR   GO; GO:0015630; C:microtubule cytoskeleton; IDA:HPA.
DR   GO; GO:0048471; C:perinuclear region of cytoplasm; IEA:UniProtKB-SubCell.
DR   GO; GO:0005102; F:signaling receptor binding; ISS:BHF-UCL.
DR   GO; GO:0005198; F:structural molecule activity; TAS:ProtInc.
DR   GO; GO:0007163; P:establishment or maintenance of cell polarity; TAS:ProtInc.
DR   GO; GO:0000226; P:microtubule cytoskeleton organization; IBA:GO_Central.
DR   GO; GO:0072659; P:protein localization to plasma membrane; ISS:BHF-UCL.
DR   GO; GO:0006970; P:response to osmotic stress; ISS:BHF-UCL.
DR   InterPro; IPR051483; MAP7_domain-containing.
DR   InterPro; IPR008604; MAP7_fam.
DR   PANTHER; PTHR15073:SF4; ENSCONSIN; 1.
DR   PANTHER; PTHR15073; MICROTUBULE-ASSOCIATED PROTEIN; 1.
DR   Pfam; PF05672; MAP7; 1.
DR   neXtProt; NX_Q14244; -.
DR   PharmGKB; PA30615; -.
DR   TreeFam; TF332273; -.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative splicing; Cell membrane;
KW   Coiled coil; Cytoplasm; Cytoskeleton; Isopeptide bond; Membrane;
KW   Microtubule; Phosphoprotein; Proteomics identification; Reference proteome;
KW   Ubl conjugation.
FT   INIT_MET        1
FT                   /note="Removed"
FT                   /evidence="ECO:0007744|PubMed:19413330"
FT   CHAIN           2..749
FT                   /note="Ensconsin"
FT                   /id="PRO_0000255949"
FT   REGION          1..91
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          104..180
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          307..688
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          702..723
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COILED          89..152
FT                   /evidence="ECO:0000255"
FT   COILED          477..612
FT                   /evidence="ECO:0000255"
FT   COMPBIAS        36..52
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        62..91
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        104..151
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        307..320
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        372..390
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        406..418
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        424..433
FT                   /note="Low complexity"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        434..450
FT                   /note="Pro residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        451..460
FT                   /note="Low complexity"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        461..473
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        478..627
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        660..672
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOD_RES         2
FT                   /note="N-acetylalanine"
FT                   /evidence="ECO:0007744|PubMed:19413330"
FT   MOD_RES         161
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   MOD_RES         165
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   MOD_RES         183
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:21406692,
FT                   ECO:0007744|PubMed:23186163"
FT   MOD_RES         200
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   MOD_RES         202
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   MOD_RES         209
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:16964243,
FT                   ECO:0007744|PubMed:18220336, ECO:0007744|PubMed:18669648,
FT                   ECO:0007744|PubMed:18691976, ECO:0007744|PubMed:20068231,
FT                   ECO:0007744|PubMed:23186163"
FT   MOD_RES         219
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:16964243,
FT                   ECO:0007744|PubMed:17924679, ECO:0007744|PubMed:18220336,
FT                   ECO:0007744|PubMed:18669648, ECO:0007744|PubMed:20068231,
FT                   ECO:0007744|PubMed:23186163"
FT   MOD_RES         231
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0007744|PubMed:18669648,
FT                   ECO:0007744|PubMed:23186163"
FT   MOD_RES         235
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:24275569"
FT   MOD_RES         254
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:16964243,
FT                   ECO:0007744|PubMed:18669648"
FT   MOD_RES         277
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0007744|PubMed:16964243,
FT                   ECO:0007744|PubMed:18669648, ECO:0007744|PubMed:20068231,
FT                   ECO:0007744|PubMed:23186163"
FT   MOD_RES         282
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   MOD_RES         335
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   MOD_RES         365
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163,
FT                   ECO:0007744|PubMed:24275569"
FT   MOD_RES         673
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0007744|PubMed:20068231"
FT   CROSSLNK        273
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0007744|PubMed:28112733"
FT   CROSSLNK        295
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0007744|PubMed:28112733"
FT   CROSSLNK        373
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0007744|PubMed:28112733"
FT   CROSSLNK        377
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0007744|PubMed:28112733"
FT   CROSSLNK        406
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0007744|PubMed:25114211,
FT                   ECO:0007744|PubMed:25218447, ECO:0007744|PubMed:25772364,
FT                   ECO:0007744|PubMed:28112733"
FT   VAR_SEQ         1..146
FT                   /note="Missing (in isoform 5)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_043335"
FT   VAR_SEQ         1..23
FT                   /note="MAELGAGGDGHRGGDGAVRSETA -> MEDTKLYS (in isoform 6)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_046758"
FT   VAR_SEQ         1..22
FT                   /note="MAELGAGGDGHRGGDGAVRSET -> MPGSATALRHERLKKTNARPIPLGLF
FT                   TINEEDEQQKNGNSRRPK (in isoform 4 and isoform 7)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_043336"
FT   VAR_SEQ         82..175
FT                   /note="Missing (in isoform 3)"
FT                   /evidence="ECO:0000303|Ref.2"
FT                   /id="VSP_021316"
FT   VAR_SEQ         176..212
FT                   /note="Missing (in isoform 2 and isoform 4)"
FT                   /evidence="ECO:0000303|PubMed:14702039, ECO:0000303|Ref.2"
FT                   /id="VSP_021317"
FT   VARIANT         361
FT                   /note="V -> I (in dbSNP:rs35350783)"
FT                   /id="VAR_034091"
FT   VARIANT         526
FT                   /note="R -> P (in dbSNP:rs35107962)"
FT                   /id="VAR_034092"
FT   VARIANT         558
FT                   /note="R -> W (in dbSNP:rs2076190)"
FT                   /evidence="ECO:0000269|PubMed:14702039,
FT                   ECO:0000269|PubMed:15489334"
FT                   /id="VAR_028880"
FT   CONFLICT        318
FT                   /note="N -> D (in Ref. 3; BAH13013)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        583
FT                   /note="Q -> R (in Ref. 3; BAH12386)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        725
FT                   /note="F -> S (in Ref. 3; BAH13013)"
FT                   /evidence="ECO:0000305"
FT   HELIX           88..138
FT                   /evidence="ECO:0007829|PDB:7SGS"
SQ   SEQUENCE   749 AA;  84052 MW;  CB69BDE25C9540E3 CRC64;
     MAELGAGGDG HRGGDGAVRS ETAPDSYKVQ DKKNASSRPA SAISGQNNNH SGNKPDPPPV
     LRVDDRQRLA RERREEREKQ LAAREIVWLE REERARQHYE KHLEERKKRL EEQRQKEERR
     RAAVEEKRRQ RLEEDKERHE AVVRRTMERS QKPKQKHNRW SWGGSLHGSP SIHSADPDRR
     SVSTMNLSKY VDPVISKRLS SSSATLLNSP DRARRLQLSP WESSVVNRLL TPTHSFLARS
     KSTAALSGEA ASCSPIIMPY KAAHSRNSMD RPKLFVTPPE GSSRRRIIHG TASYKKERER
     ENVLFLTSGT RRAVSPSNPK ARQPARSRLW LPSKSLPHLP GTPRPTSSLP PGSVKAAPAQ
     VRPPSPGNIR PVKREVKVEP EKKDPEKEPQ KVANEPSLKG RAPLVKVEEA TVEERTPAEP
     EVGPAAPAMA PAPASAPAPA SAPAPAPVPT PAMVSAPSST VNASASVKTS AGTTDPEEAT
     RLLAEKRRLA REQREKEERE RREQEELERQ KREELAQRVA EERTTRREEE SRRLEAEQAR
     EKEEQLQRQA EERALREREE AERAQRQKEE EARVREEAER VRQEREKHFQ REEQERLERK
     KRLEEIMKRT RRTEATDKKT SDQRNGDIAK GALTGGTEVS ALPCTTNAPG NGKPVGSPHV
     VTSHQSKVTV ESTPDLEKQP NENGVSVQNE NFEEIINLPI GSKPSRLDVT NSESPEIPLN
     PILAFDDEGT LGPLPQVDGV QTQQTAEVI
//
